At Medecision, we are committed to staying at the forefront of discussions about industry-wide issues—such as pharmaceutical drug pricing. Health economist Jane Sarasohn-Kahn gives her insights into the recent conversations…
The U.S. Department of Health and Human Services has prioritized efforts to contain the COVID-19 pandemic over enforcing HIPAA rules.
America is in the midst of a mental health crisis—but hospitals and community-based organizations can partner together to identify and diagnose mental health issues before they worsen. Medecision is committed…
At Medecision, we are committed to improving healthcare and health equity for all and feel it’s important to highlight the voices championing an equitable healthcare system. That’s why we’re happy…
The COVID-19 pandemic put consumer trust to the test in 2020 and early 2021. Health economist Jane Sarasohn-Kahn shares how the healthcare industry can help rebuild trust among health citizens.
A game-changing revision to CMS rules for Star ratings puts Medicare Advantage plans under extra pressure to deliver an excellent customer experience. At Medecision, our solutions and services help health…
At Medecision, we understand the value of virtual care. But until we make the processes easy and accessible, we’re not going to change the ability of all people to access…
Guest blogger Jane Sarasohn-Kahn shares how recent acquisitions of telehealth companies means telehealth and virtual care is now a regular form of healthcare delivery.
Medecision is committed to helping the healthcare system achieve the Quadruple Aim, and a key component of that is improving the patient experience. During this National Patient Experience Week, we…
Terry McInnis, MD, MPH, CPE, president of Blue Thorn Inc. and member of the Medecision Advisory Board; and Terri Steinberg, MD, MBA, FACP, FAMIA, Medecision’s Group Senior Vice President of…
